{"disease":{"id":"viremia","name":"viremia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06604663","title":"Data Science and Qualitative Research for Decision Support in the HIV Care Cascade","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":80000,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT07021092","title":"PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Centre for Infectious Disease Research in Zambia","has_results":false},{"nct_id":"NCT04412811","title":"Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT","phase":"","overall_status":"COMPLETED","enrollment_count":1310,"lead_sponsor_name":"Gruppo Italiano Trapianto di Midollo Osseo","has_results":false},{"nct_id":"NCT06681025","title":"Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1070,"lead_sponsor_name":"QIAGEN Gaithersburg, Inc","has_results":false},{"nct_id":"NCT04546971","title":"Using Telehealth to Address Alcohol Misuse in HIV Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT05845619","title":"Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":550,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT04189835","title":"EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":509,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06263218","title":"Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":false},{"nct_id":"NCT05203055","title":"Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Fuzhou General Hospital","has_results":false},{"nct_id":"NCT05325008","title":"A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT06629753","title":"Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":278,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05377463","title":"Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"University of Texas, El Paso","has_results":false},{"nct_id":"NCT01488526","title":"Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"New Discovery LLC","has_results":false},{"nct_id":"NCT06999928","title":"Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT03443791","title":"Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT07079735","title":"Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06646562","title":"Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia","has_results":false},{"nct_id":"NCT04769167","title":"Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07347769","title":"Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT05769582","title":"Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Memo Therapeutics AG","has_results":false},{"nct_id":"NCT05432778","title":"Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT02136797","title":"Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT05224583","title":"Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT05799716","title":"Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT04298502","title":"The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04320303","title":"CMV Infection and Immune Intervention After Transplantation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04018261","title":"Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Banc de Sang i Teixits","has_results":false},{"nct_id":"NCT07438067","title":"EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Daihong Liu","has_results":false},{"nct_id":"NCT03374202","title":"Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06011486","title":"Expansion of Virus-Specific Lymphocytes for Cell Therapy","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT03798301","title":"Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT02822495","title":"Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false},{"nct_id":"NCT03010332","title":"Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}